Author, as appears in the article.: Berenguer, Juan; Bohlius, Julia; Bouteloup, Vincent; Bucher, Heiner; Cozzi-Lepri, Alessandro; Dabis, Francois; Monforte, Antonella d'Arminio; Davies, Mary-Anne; del Amo, Julia; Dorrucci, Maria; Dunn, David; Egger, Matthias; Furrer, Hansjakob; Guiguet, Marguerite; Grabar, Sophie; Judd, Ali; Kirk, Ole; Lambotte, Olivier; Leroy, Valeriane; Lodi, Sara; Matheron, Sophie; Meyer, Laurence; Miro, Jose M.; Mocroft, Amanda; Monge, Susana; Nakagawa, Fumiyo; Paredes, Roger; Phillips, Andrew; Puoti, Massimo; Schomaker, Michael; Smit, Colette; Sterne, Jonathan; Thiebaut, Rodolphe; Thorne, Claire; Torti, Carlo; van der Valk, Marc; Wittkop, Linda; Wyss, Natasha;Late Presenters Working Grp COHERE
Department: Medicina i Cirurgia
URV's Author/s: Vidal Marsal, Francisco
Keywords: Trends People Late presentation Infection Human immunodeficiency virus - hiv Health Era Epidemiology Count Consensus definition Combination antiretroviral therapy Cohort Burden
Abstract: Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-European update from 34 countries on the prevalence and risk factors of LP for 2010-2013. People aged >= 16 presenting for HIV care (earliest of HIV-diagnosis, first clinic visit or cohort enrolment) after 1 January 2010 with available CD4 count within six months of presentation were included. LP was defined as presentation with a CD4 count < 350/mm(3) or an AIDS defining event (at any CD4), in the six months following HIV diagnosis. Logistic regression investigated changes in LP over time. A total of 30,454 people were included. The median CD4 count at presentation was 368/mm(3) (interquartile range (IQR) 193-555/mm(3)), with no change over time (p = 0.70). In 2010, 4,775/10,766 (47.5%) were LP whereas in 2013, 1,642/3,375 (48.7%) were LP (p = 0.63). LP was most common in central Europe (4,791/9,625, 49.8%), followed by northern (5,704/11,692; 48.8%), southern (3,550/7,760; 45.8%) and eastern Europe (541/1,377; 38.3%; p < 0.0001). There was a significant increase in LP in male and female people who inject drugs (PWID) (adjusted odds ratio (aOR)/year later 1.16; 95% confidence interval (CI): 1.02-1.32), and a significant decline in LP in northern Europe (aOR/year later 0.89; 95% CI: 0.85-0.94). Further improvements in effective HIV testing strategies, with a focus on vulnerable groups, are required across the European continent.
Thematic Areas: Virology Saúde coletiva Public health, environmental and occupational health Medicine (miscellaneous) Medicina veterinaria Medicina ii Medicina i Infectious diseases General medicine Farmacia Epidemiology Ciências biológicas iii Ciências agrárias i Biotecnología
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Author's mail: francesc.vidal@urv.cat
Author identifier: 0000-0002-6692-6186
Record's date: 2024-09-07
Papper version: info:eu-repo/semantics/publishedVersion
Link to the original source: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2015.20.47.30070
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Papper original source: Eurosurveillance. 20 (47): 7-18
APA: Berenguer, Juan; Bohlius, Julia; Bouteloup, Vincent; Bucher, Heiner; Cozzi-Lepri, Alessandro; Dabis, Francois; Monforte, Antonella d'Arminio; Davies, (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Eurosurveillance, 20(47), 7-18. DOI: 10.2807/1560-7917.ES.2015.20.47.30070
Article's DOI: 10.2807/1560-7917.ES.2015.20.47.30070
Entity: Universitat Rovira i Virgili
Journal publication year: 2015
Publication Type: Journal Publications
Repositori URV